Sohag university hosoital
Sohag, Egypt
Location status: Recruiting
Recruiting
NCT Number: NCT06498141
MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases
This is an observertional study aimed at Study the association between Mucin B5 rs (35705950) gene polymorphism and Leucocytes telomere length in relation to interstitial lung diseases.
Recruiting
Interested in participating?
Request InfoKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
This study will include patients with interstitial lung diseases aged above 18 years old.
Exclusion criteria
- patients with emphysema or obstructive lung diseases.
- patients with active cancer
- End stage renal failure (GFR < 30 ml/min) or on dialysis
- Liver cell failure
Treatment and study plan
Primary outcomes
-
MucinB5 rs (35705950) gene polymorphism
Time frame: 6 Months
whether homogenetic or heterogenetic
-
Leucocytes telomere length
Time frame: 6 months
Measurement of the relative length of WBCs telomere in patints with interstitial pulmonary fibrosis
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Sohag University
Other
Registry information
Official study title
MucinB5 rs (35705950) Gene Polymorphism and Leucocytes Telomere Length in Relation to Interstitial Lung Diseases.
Important dates
- Study start
- 2023
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Jul 12, 2024
- Registry last updated
- Jul 12, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.